Compare ABTC & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABTC | ALLO |
|---|---|---|
| Founded | 2024 | 2017 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 386.0M | 452.6M |
| IPO Year | 2020 | 2018 |
| Metric | ABTC | ALLO |
|---|---|---|
| Price | $4.30 | $0.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $15.75 | $9.00 |
| AVG Volume (30 Days) | 943.3K | ★ 11.2M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.67 | 34.09 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $185,164,000.00 | N/A |
| Revenue This Year | $46.17 | N/A |
| Revenue Next Year | $18.18 | $72.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 801.52 | N/A |
| 52 Week Low | $4.27 | $0.74 |
| 52 Week High | $374.25 | $4.46 |
| Indicator | ABTC | ALLO |
|---|---|---|
| Relative Strength Index (RSI) | 27.23 | 21.26 |
| Support Level | N/A | N/A |
| Resistance Level | $9.16 | $2.25 |
| Average True Range (ATR) | 0.54 | 0.10 |
| MACD | -0.14 | -0.02 |
| Stochastic Oscillator | 0.14 | 0.42 |
American Bitcoin Corp is a Bitcoin accumulation platform that integrates scaled Bitcoin mining operations with disciplined accumulation strategies. Its business is engaged in the operation of application-specific integrated circuit ("ASIC") miners for mining Bitcoin and the strategic accumulation of a Bitcoin reserve.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).